Recent discoveries suggest that the expression of distinct members of the NEUROD family could serve as biomarkers at the onset of various neurological diseases, such as Alzheimer’s disease, and also serve in the development of patient-oriented gene therapies. Here, NEUROD1 is linked to early-onset autosomal dominant Alzheimer disease.